Transurethral resection, neoadjuvant chemotherapy and accelerated hyperfractionated radiotherapy (concomitant boost), with or without concurrent cisplatin, for patients with invasive bladder cancer – clinical outcome

AIM OF THE STUDY: To evaluate the toxicity, clinical effectiveness and survival rate of transurethral resection, neoadjuvant chemotherapy and accelerated hyperfractionated radiotherapy (concomitant boost), with or without concurrent cisplatin in patients with muscle invasive bladder cancer. MATERIAL...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Nowak-Sadzikowska, Jadwiga, Jakubowicz, Jerzy, Skóra, Tomasz, Pudełek, Katarzyna
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Termedia Publishing House 2013
Aiheet:
Original Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3934068/
https://ncbi.nlm.nih.gov/pubmed/24596519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2013.35276
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia